Wnt signaling in cancer.
Open accessThe DOI matches its Crossref record; 90 of the 94 references it cites were found in a registry or an index.
Abstract
Aberrant regulation of the Wnt signaling pathway is a prevalent theme in cancer biology. From the earliest observation that Wnt overexpression could lead to malignant transformation of mouse mammary tissue to the most recent genetic discoveries gleaned from tumor genome sequencing, the Wnt pathway continues to evolve as a central mechanism in cancer biology. This article summarizes the evidence supporting a role for Wnt signaling in human cancer. This includes a review of the genetic mutations affecting Wnt pathway components, as well as some of epigenetic mechanisms that alter expression of genes relevant to Wnt. I also highlight some research on the cooperativity of Wnt with other signaling pathways in cancer. Finally, some emphasis is placed on laboratory research that provides a proof of concept for the therapeutic inhibition of Wnt signaling in cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, APC, as a gene that upregulates WNT signaling, is negatively correlated with the frequency of T cell infiltration [196,197,198].”
From Drug Resistance in Colorectal Cancer: From Mechanism to Clinic (2022) · cites this paper as [197]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Repeated observation of breast tumor subtypes in independent gene expression data sets
Sørlie, T., Tibshirani, R., Parker, J., Hastie, T., Marron, J. S., Nobel, A., Deng, S., Johnsen, H., Pesich, R., Geisler, S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0932692100 · Cited by 5,429 · cited 1×
“Expression of the Wnt receptor FZD7 is characteristic of these types of breast cancer (Sorlie et al. 2003).”
BackgroundWnt signalling in stem cells and cancer
Reya, T., & Clevers, H. (2005) · Nature · doi:10.1038/nature03319 · Cited by 3,666 · cited 1×
“The impact ofb-catenin knockdown in cancers without identifiable genetic lesions in Wnt signaling could relate to the purported role of Wnt in the establishment and maintenance of so-called cancer stem cells (CSCs) (Reya and Clevers 2005; Malanchi and Huelsken 2009).”
Backgroundβ-Catenin regulates expression of cyclin D1 in colon carcinoma cells
Tetsu, O., & McCormick, F. (1999) · Nature · doi:10.1038/18884 · Cited by 3,601 · cited 1×
“Consequently, inhibition of target gene activation in colorectal cancer cells expressing the dominant negative TCF4 resulted in their growth arrest (Tetsu and McCormick 1999; van de Wetering et al. 2002).”
BackgroundThe Consensus Coding Sequences of Human Breast and Colorectal Cancers
Sjöblom, T., Jones, S., Wood, L. D., Parsons, D. W., Lin, J., Barber, T. D., Mandelker, D., Leary, R. J., Ptak, J., Silliman, N., et al. (2006) · Science · doi:10.1126/science.1133427 · Cited by 3,169 · cited 1×
“Paradoxically, mutations in TCF4, identified through genomic sequencing efforts of colorectal cancers, appear to be inactivating by compromising its ability to repress cell growth (Sjoblom et al. 2006; Tang et al. 2008).”
BackgroundThe M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06734 · Cited by 2,820 · cited 1×
“PKM2 has received considerable attention lately, although mainly because of a renewed interest in the role of metabolism and aerobic glycolysis in cancer (Christofk et al. 2008).”
BackgroundThe β-Catenin/TCF-4 Complex Imposes a Crypt Progenitor Phenotype on Colorectal Cancer Cells
van de Wetering, M., Sancho, E., Verweij, C., de Lau, W., Oving, I., Hurlstone, A., van der Horn, K., Batlle, E., Coudreuse, D., Haramis, A.-P., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)01014-0 · Cited by 2,030
Wnt signalling and its impact on development and cancer
Klaus, A., & Birchmeier, W. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2389 · Cited by 1,595 · cited 1×
“Ultimately, the TCF transcription factors that associated with b-catenin completed the understanding of a basic signaling pathway that could account for the potent tumori- genic effects of Wnt (reviewed by Klaus and Birchmeier 2008).”
Backgroundvan Es, J. H., van Gijn, M. E., Riccio, O., van den Born, M., Vooijs, M., Begthel, H., Cozijnsen, M., Robine, S., Winton, D. J., Radtke, F., et al. (2005) · Nature · doi:10.1038/nature03659 · Cited by 1,543 · cited 1×
“The impact of Notch in the intestine was consistent with previous work showing that its activation or inhibition increased or decreased the population of proliferating/progenitor cells, respectively, at the expense of the differentiated population (Fre et al. 2005; van Es et al. 2005).”
ResultMorin, R. D., Johnson, N. A., Severson, T. M., Mungall, A. J., An, J., Goya, R., Paul, J. E., Boyle, M., Woolcock, B. W., Kuchenbauer, F., et al. (2010) · Nature Genetics · doi:10.1038/ng.518 · Cited by 1,521
Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML
Jamieson, C. H. M., Ailles, L. E., Dylla, S. J., Muijtjens, M., Jones, C., Zehnder, J. L., Gotlib, J., Li, K., Manz, M. G., Keating, A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040258 · Cited by 1,485 · cited 1×
“Granulocyticmacrophage progenitors isolated from CML patients show attributes of excessive Wnt signaling relative to normal progenitors and the introduction of the Wnt pathway inhibitor Axin decreased their capacity for proliferation and self-renewal (Jamieson et al. 2004).”
Background
Cited by
Zhan, T., Rindtorff, N., & Boutros, M. (2017) · Oncogene · doi:10.1038/onc.2016.304 · Cited by 2,626
The complex world of WNT receptor signalling
Niehrs, C. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3470 · Cited by 1,492
Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974
Liu, J., Pan, S., Hsieh, M. H., Ng, N., Sun, F., Wang, T., Kasibhatla, S., Schuller, A. G., Li, A. G., Cheng, D., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1314239110 · Cited by 831
“In addition, overexpression of Wnt ligands or costimulants, such as R-Spondin 2/3 (RSPO2/3), or silencing of Wnt inhibitor genes has been reported in various cancers (1, 4).”
BackgroundInfluentialScientific Opinion on acrylamide in food
(CONTAM), E. P. O. C. I. T. F. C. (2015) · EFSA Journal · doi:10.2903/j.efsa.2015.4104 · Cited by 828
“The deregulation of this pathway has been reported in different malignancies (Polakis, 2012).”
BackgroundSustained proliferation in cancer: Mechanisms and novel therapeutic targets
Feitelson, M. A., Arzumanyan, A., Kulathinal, R. J., Blain, S. W., Holcombe, R. F., Mahajna, J., Marino, M., Martinez-Chantar, M. L., Nawroth, R., Sanchez-Garcia, I., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.02.006 · Cited by 778
Wnt Signaling Pathway in Non-Small Cell Lung Cancer
Stewart, D. J. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt356 · Cited by 651
Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy
Li, Q., Geng, S., Luo, H., Wang, W., Mo, Y.-Q., Luo, Q., Wang, L., Song, G.-B., Sheng, J.-P., & Xu, B. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01953-7 · Cited by 546
Mutations and mechanisms of WNT pathway tumour suppressors in cancer
Bugter, J. M., Fenderico, N., & Maurice, M. M. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-020-00307-z · Cited by 466
The Wnt Pathway: From Signaling Mechanisms to Synthetic Modulators
Rim, E. Y., Clevers, H., & Nusse, R. (2022) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-040320-103615 · Cited by 483
Tight Junction Proteins and Signaling Pathways in Cancer and Inflammation: A Functional Crosstalk
Bhat, A. A., Uppada, S., Achkar, I. W., Hashem, S., Yadav, S. K., Shanmugakonar, M., Al-Naemi, H. A., Haris, M., & Uddin, S. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2018.01942 · Cited by 400
“Mislocalization of β-catenin and dysregulation of Wnt/β-catenin signaling pathway is shown to be associated with development of various cancers (Polakis, 2012; Keerthivasan et al., 2014; Wang et al., 2014).”
BackgroundSignaling pathways involved in colorectal cancer progression
Koveitypour, Z., Panahi, F., Vakilian, M., Peymani, M., Seyed Forootan, F., Nasr Esfahani, M. H., & Ghaedi, K. (2019) · Cell & Bioscience · doi:10.1186/s13578-019-0361-4 · Cited by 393
Wnt signaling in adult intestinal stem cells and cancer
Krausova, M., & Korinek, V. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2013.11.032 · Cited by 361
Forty Years of Clathrin‐coated Vesicles
Robinson, M. S. (2015) · Traffic · doi:10.1111/tra.12335 · Cited by 356
“Drosophila screens for odd-looking mutants (190, 191) but are now of clinical interest because they are often dysregulated in cancer (192, 193).”
Role of Cadherins in Cancer—A Review
Kaszak, I., Witkowska-Piłaszewicz, O., Niewiadomska, Z., Dworecka-Kaszak, B., Ngosa Toka, F., & Jurka, P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207624 · Cited by 356
“During tumorigenesis, due to the phosphorylation, β-catenin is released into the cytoplasm (also as a consequence of E-cadherin loss) and communicates with a protein complex composed of Axin, adenomatous polyposis coli (APC) and the Ser/Thr kinase glycogen synthase 3β (GSK-3β) [17,31].”
BackgroundInfluentialJi, H., Greening, D. W., Barnes, T. W., Lim, J. W., Tauro, B. J., Rai, A., Xu, R., Adda, C., Mathivanan, S., Zhao, W., et al. (2013) · PROTEOMICS · doi:10.1002/pmic.201200562 · Cited by 357
“activating mutations of the TCF4/ -catenin transcriptional program, leads to tumorigenesis [80].”
BackgroundWnt signaling in bone formation and its therapeutic potential for bone diseases
Kim, J. H., Liu, X., Wang, J., Chen, X., Zhang, H., Kim, S. H., Cui, J., Li, R., Zhang, W., Kong, Y., et al. (2013) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x12466608 · Cited by 356
“com fact, these oncogenic risks have been well documented with mutations of Wnt signaling mediators such as APC, Axin, GSK3β, β catenin and LRP [Polakis, 2012].”
BackgroundCancer stem cell signaling pathways
Matsui, W. H. (2016) · Medicine · doi:10.1097/md.0000000000004765 · Cited by 320
Aung, T., Qu, Z., Kortschak, R., & Adelson, D. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030656 · Cited by 319
Steinhart, Z., Pavlovic, Z., Chandrashekhar, M., Hart, T., Wang, X., Zhang, X., Robitaille, M., Brown, K. R., Jaksani, S., Overmeer, R., et al. (2017) · Nature Medicine · doi:10.1038/nm.4219 · Cited by 297
Wnt signaling in triple-negative breast cancer
Pohl, S.-G., Brook, N., Agostino, M., Arfuso, F., Kumar, A. P., & Dharmarajan, A. (2017) · Oncogenesis · doi:10.1038/oncsis.2017.14 · Cited by 296
WNT Signaling in Tumors: The Way to Evade Drugs and Immunity
Martin-Orozco, E., Sanchez-Fernandez, A., Ortiz-Parra, I., & Ayala-San Nicolas, M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02854 · Cited by 286
“Since WNT signaling is crucial to immune homeostasis, alterations of this pathway in pathologies such as cancer can also be associated with the profound dysregulation of protective antitumoral immune responses [reviewed in (45, 66, 67)].”
BackgroundTargeting signaling pathways in prostate cancer: mechanisms and clinical trials
He, Y., Xu, W., Xiao, Y.-T., Huang, H., Gu, D., & Ren, S. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01042-7 · Cited by 261
“7).(65,441,442) When WNT ligands bind to frizzled (FZD) receptors and co-receptors LRP5/6, LRP5/6 are phosphorylated by CK1 and GSK3, and then the signal is transduced to activate the cytoplasmic phosphoprotein dishevelled (DVL).”
BackgroundYang, Y., Li, H., Hou, S., Hu, B., Liu, J., & Wang, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065309 · Cited by 263
“The Wnt pathway has now been found to be altered in many types of cancer [16].”
BackgroundThe wound healing, chronic fibrosis, and cancer progression triad
Rybinski, B., Franco-Barraza, J., & Cukierman, E. (2014) · Physiological Genomics · doi:10.1152/physiolgenomics.00158.2013 · Cited by 253
A central role for cadherin signaling in cancer
Kourtidis, A., Lu, R., Pence, L. J., & Anastasiadis, P. Z. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.04.006 · Cited by 250
Vitamin D and Cancer: An Historical Overview of the Epidemiology and Mechanisms
Muñoz, A., & Grant, W. B. (2022) · Nutrients · doi:10.3390/nu14071448 · Cited by 234
“The Wnt/β-catenin pathway is an important player in cancer as it is aberrantly activated by mutation (APC, AXIN, CTNNB1/β-catenin, RSPO2/3, and RNF43 genes), overexpression of Wnt factors/receptors or silencing of Wnt signaling inhibitors (DICKKOPF/DKKs, SFRPs) leading to the activation or potentiation of carcinogenes…”
BackgroundSteinway, S. N., Zañudo, J. G. T., Ding, W., Rountree, C. B., Feith, D. J., Loughran, T. P., & Albert, R. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0225 · Cited by 228
“For example, Wnt pathway induction of EMT has been demonstrated in multiple cancer types(42).”
Cellular and molecular mechanisms of hepatocellular carcinoma: an update
Aravalli, R. N., Cressman, E. N. K., & Steer, C. J. (2013) · Archives of Toxicology · doi:10.1007/s00204-012-0931-2 · Cited by 225
“It is deregulated in a number of cancers including HCC (Polakis 2012).”
BackgroundTCF / LEF dependent and independent transcriptional regulation of Wnt/β‐catenin target genes
Doumpas, N., Lampart, F., Robinson, M. D., Lentini, A., Nestor, C. E., Cantù, C., & Basler, K. (2019) · The EMBO Journal · doi:10.15252/embj.201798873 · Cited by 225
“The importance of so-called canonical Wnt signalling goes beyond embryonic development, as its constitutive activation has been implicated in the pathogenesis of several different cancers and hereditary diseases (Laudes, 2011; Clevers & Nusse, 2012; Polakis, 2012; Kahn, 2014).”
Exon 3 mutations of CTNNB1 drive tumorigenesis: a review
Gao, C., Wang, Y., Broaddus, R., Sun, L., Xue, F., & Zhang, W. (2018) · Oncotarget · doi:10.18632/oncotarget.23695 · Cited by 224
“Thus, abnormal expression of β-catenin in the cytoplasm and nucleus is regarded as an important indicator of malignancy [6, 79].”
BackgroundNg, L., Kaur, P., Bunnag, N., Suresh, J., Sung, I., Tan, Q., Gruber, J., & Tolwinski, N. (2019) · Cells · doi:10.3390/cells8080826 · Cited by 212
Metabolic Reprogramming of Colorectal Cancer Cells and the Microenvironment: Implication for Therapy
Nenkov, M., Ma, Y., Gaßler, N., & Chen, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126262 · Cited by 218
Conceptual Evolution of Cell Signaling
Nair, A., Chauhan, P., Saha, B., & Kubatzky, K. F. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133292 · Cited by 217
Molecular targets of curcumin for cancer therapy: an updated review
Kasi, P. D., Tamilselvam, R., Skalicka-Woźniak, K., Nabavi, S. F., Daglia, M., Bishayee, A., Pazoki-toroudi, H., & Nabavi, S. M. (2016) · Tumor Biology · doi:10.1007/s13277-016-5183-y · Cited by 216
“Overexpression of β-catenin leads to constitutive activation of cell proliferation [88].”
BackgroundMesenchymal Stem Cell-Mediated Effects of Tumor Support or Suppression
Rhee, K.-J., Lee, J., & Eom, Y. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161226215 · Cited by 214
Heng, B. C., Aubel, D., & Fussenegger, M. (2013) · Biotechnology Advances · doi:10.1016/j.biotechadv.2013.08.017 · Cited by 204
“catenin signaling, as seen by overexpression of both Wnt receptors and ligands in cancerous tissues (Park et al., 2009; Polakis, 2012).”
BackgroundVervoort, S. J., van Boxtel, R., & Coffer, P. J. (2013) · Oncogene · doi:10.1038/onc.2012.506 · Cited by 198
Effects of Intestinal Microbial–Elaborated Butyrate on Oncogenic Signaling Pathways
Chen, J., Zhao, K.-N., & Vitetta, L. (2019) · Nutrients · doi:10.3390/nu11051026 · Cited by 198
Wnt Signaling and the Control of Human Stem Cell Fate
Van Camp, J. K., Beckers, S., Zegers, D., & Van Hul, W. (2014) · Stem Cell Reviews and Reports · doi:10.1007/s12015-013-9486-8 · Cited by 196
Evolutionary conservation of early mesoderm specification by mechanotransduction in Bilateria
Brunet, T., Bouclet, A., Ahmadi, P., Mitrossilis, D., Driquez, B., Brunet, A.-C., Henry, L., Serman, F., Béalle, G., Ménager, C., et al. (2013) · Nature Communications · doi:10.1038/ncomms3821 · Cited by 191
Collateral damage: Insights into bacterial mechanisms that predispose host cells to cancer
Gagnaire, A., Nadel, B., Raoult, D., Neefjes, J., & Gorvel, J.-P. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.171 · Cited by 189
The curious case of vacuolar ATPase: regulation of signaling pathways
Pamarthy, S., Kulshrestha, A., Katara, G. K., & Beaman, K. D. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0811-3 · Cited by 182
“In humans, dysregulation of Wnt signaling has been implicated in cancer [79].”
BackgroundLv, C., Li, F., Li, X., Tian, Y., Zhang, Y., Sheng, X., Song, Y., Meng, Q., Yuan, S., Luan, L., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01059-5 · Cited by 183
Mesenchymal stem cells as a double-edged sword in tumor growth: focusing on MSC-derived cytokines
Liang, W., Chen, X., Zhang, S., Fang, J., Chen, M., Xu, Y., & Chen, X. (2021) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-020-00246-5 · Cited by 180
Rodon, J., Argilés, G., Connolly, R. M., Vaishampayan, U., de Jonge, M., Garralda, E., Giannakis, M., Smith, D. C., Dobson, J. R., McLaughlin, M. E., et al. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01389-8 · Cited by 174
Inflammation and Colorectal Cancer
Long, A. G., Lundsmith, E. T., & Hamilton, K. E. (2017) · Current Colorectal Cancer Reports · doi:10.1007/s11888-017-0373-6 · Cited by 174
Bilir, B., Kucuk, O., & Moreno, C. S. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-280 · Cited by 175
“Wnt signaling regulates cell proliferation, survival, and differentiation, and plays key roles in embryonic development and tumorigenesis [14-17].”
Backgroundβ-Catenin-Independent Roles of Wnt/LRP6 Signaling
Acebron, S. P., & Niehrs, C. (2016) · Trends in Cell Biology · doi:10.1016/j.tcb.2016.07.009 · Cited by 175
Hao, H.-X., Jiang, X., & Cong, F. (2016) · Cancers · doi:10.3390/cancers8060054 · Cited by 171
“These include truncation mutations of APC, stabilization mutations of β-catenin and loss/gain-of-function mutations of AXIN1 [35].”
BackgroundInfluentialWnts in adult brain: from synaptic plasticity to cognitive deficiencies
Oliva, C. A., Vargas, J. Y., & Inestrosa, N. C. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00224 · Cited by 162
“Wnt signaling has been implicated in various diseases, including colon cancer and melanoma (Polakis, 2012), and also in neurodegenerative diseases (Inestrosa and Arenas, 2010; Berwick and Harvey, 2012), reflecting its relevance in fundamental biological processes across species (Clevers and Nusse,…”
BackgroundInfluentialThe role of the Wnt canonical signaling in neurodegenerative diseases
Libro, R., Bramanti, P., & Mazzon, E. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.06.024 · Cited by 163
The pluripotency factor nanog promotes breast cancer tumorigenesis and metastasis
Lu, X., Mazur, S. J., Lin, T., Appella, E., & Xu, Y. (2014) · Oncogene · doi:10.1038/onc.2013.209 · Cited by 163
MicroRNAs and cancer stem cells: the sword and the shield
Sun, X., Jiao, X., Pestell, T. G., Fan, C., Qin, S., Mirabelli, E., Ren, H., & Pestell, R. G. (2014) · Oncogene · doi:10.1038/onc.2013.492 · Cited by 161
Resistance to endocrine therapy in breast cancer: molecular mechanisms and future goals
Szostakowska, M., Trębińska-Stryjewska, A., Grzybowska, E. A., & Fabisiewicz, A. (2019) · Breast Cancer Research and Treatment · doi:10.1007/s10549-018-5023-4 · Cited by 161
Inhibition of Tankyrases Induces Axin Stabilization and Blocks Wnt Signalling in Breast Cancer Cells
Bao, R., Christova, T., Song, S., Angers, S., Yan, X., & Attisano, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048670 · Cited by 161
“divergent chemotypes, some of which have been characterized and similarly shown to promote stabilization of Axin in vitro and in vivo [1,23,24,25,26,27,28].”
InfluentialStichelen, S. O., Dehennaut, V., Buzy, A., Zachayus, J., Guinez, C., Mir, A., Yazidi‐Belkoura, I. E., Copin, M., Boureme, D., Loyaux, D., et al. (2014) · The FASEB Journal · doi:10.1096/fj.13-243535 · Cited by 161
“axin, TCF4, LRP5, and -catenin genes (8).”
Drug Resistance in Colorectal Cancer: From Mechanism to Clinic
Wang, Q., Shen, X., Chen, G., & Du, J. (2022) · Cancers · doi:10.3390/cancers14122928 · Cited by 160
Vadlakonda, L., Pasupuleti, M., & Pallu, R. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00085 · Cited by 158
“Aberrant activation of Wnt pathway was shown to lead cells to malignant transformation (Polakis, 2012).”
BackgroundEmerging Roles of Wnt Ligands in Human Colorectal Cancer
Nie, X., Liu, H., Liu, L., Wang, Y., & Chen, W. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01341 · Cited by 160
“An aberrant regulation of any of the steps mentioned above in canonical Wnt signaling could contribute to the development of human malignancies, and several studies have well-documented the impact of Wnt signaling on the carcinogenesis of CRC (9, 11).”
BackgroundTargeting Cancer Stem Cells to Overcome Chemoresistance
Nunes, T., Hamdan, D., Lebœuf, C., Bouchtaoui, M. E., Gapihan, G., Nguyen, T. T. N., Meles, S., Angeli, E., Ratajczak, P., Lu, H., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19124036 · Cited by 164
“In addition to its role in maintaining stemness, WNT/β-catenin pathway is involved in EMT transition and metastatic process in many different cancers [76], including medulloblastoma, breast, gastric, and colorectal cancers [79].”
BackgroundZhang, Z., Cheng, L., Li, J., Farah, E., Atallah, N. M., Pascuzzi, P. E., Gupta, S., & Liu, X. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3006 · Cited by 157
“Aberrant activation of Wnt signaling contributes to the progression of several major human cancers, including colorectal, liver and prostate cancer (16).”
BackgroundMortensen, M. M., Høyer, S., Lynnerup, A.-S., Orntoft, T. F., Sørensen, K. D., Borre, M., & Dyrskjøt, L. (2015) · Scientific Reports · doi:10.1038/srep16018 · Cited by 152
“Since WNT signaling promotes tumor growth, WNT antagonists generally function as tumor suppressors 22 .”
Kang, J., Jang, J.-E., Mishra, S. K., Lee, H.-J., Nho, C. W., Shin, D., Jin, M., Kim, M. K., Choi, C., & Oh, S. H. (2015) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2015.07.030 · Cited by 151
Aghabozorgi, A. S., Bahreyni, A., Soleimani, A., Bahrami, A., Khazaei, M., Ferns, G. A., Avan, A., & Hassanian, S. M. (2018) · Biochimie · doi:10.1016/j.biochi.2018.11.003 · Cited by 174
Direct targeting of β ‐catenin in the Wnt signaling pathway: Current progress and perspectives
Wang, Z., Li, Z., & Ji, H. (2021) · Medicinal Research Reviews · doi:10.1002/med.21787 · Cited by 145
Vitamin D Is a Multilevel Repressor of Wnt/b-Catenin Signaling in Cancer Cells
Larriba, M. J., González‐Sancho, J. M., Barbáchano, A., Niell, N., Ferrer‐Mayorga, G., & Múñoz, A. (2013) · Cancers · doi:10.3390/cancers5041242 · Cited by 148
“In particular, activation of the Wnt/-catenin pathway is the initial event in a high proportion of colorectal carcinomas [11,14], and recent massive sequencing has shown that over 94%”
BackgroundTargeting the Wnt pathways for therapies
Blagodatski, A. S., Poteryaev, D. A., & Katanaev, V. L. (2014) · Molecular and Cellular Therapies · doi:10.1186/2052-8426-2-28 · Cited by 167
“A large number of preclinical experiments demonstrated that inhibition of Wnt/β-catenin signaling can affect cancer cell growth and survival (for review see [29]).”
BackgroundRecent Development of Wnt Signaling Pathway Inhibitors for Cancer Therapeutics
Harb, J. F., Lin, P.-J., & Hao, J. (2019) · Current Oncology Reports · doi:10.1007/s11912-019-0763-9 · Cited by 146
Triple-negative breast cancer: new perspectives for targeted therapies
Tomao, F., Tomao, F., Rossi, L., Zaccarelli, E., Caruso, D., Minozzi, M., Frati, L., Papa, A., & Vici (2015) · OncoTargets and Therapy · doi:10.2147/ott.s67673 · Cited by 159
“wnt/Frizzled Wnt signaling is a key oncogenic pathway in multiple cancers and regulates cell proliferation, migration, and differentiation.(153,154) Wnt proteins, which are secreted glycoproteins, bind to the low-density lipoprotein receptor-related protein 5/6 (LRP5/6) and Frizzled (FZD), a seven-pass transmembrane r…”
Xiao, Q., Wu, J., Wang, W.-J., Chen, S., Zheng, Y., Yu, X., Meeth, K., Sahraei, M., Bothwell, A. L. M., Chen, L., et al. (2018) · Nature Medicine · doi:10.1038/nm.4496 · Cited by 130
“More than 80% of CRCs harbor loss of function mutations in the adenomatosis polyposis coli (APC) gene, a suppressor of the Wnt-β -catenin pathway 26 .”
Mutation Hotspots in the β-Catenin Gene: Lessons from the Human Cancer Genome Databases.
Kim, S., & Jeong-Yu, S. (2019) · PubMed Central · doi:10.14348/molcells.2018.0436 · Cited by 203
“β-Catenin is an important co-activator downstream of the oncogenic Wnt signaling pathway, so mutations in the βcatenin gene (CTNNB1) have been implicated in oncogenesis (Korinek et al., 1997; Morin et al., 1997; Polakis, 2012b).”
BackgroundMethodInfluentialWnt/β-Catenin Signaling Pathway in the Development and Progression of Colorectal Cancer
He, K., & Gan, W.-J. (2023) · Cancer Management and Research · doi:10.2147/cmar.s411168 · Cited by 166
“In the absence of Wnt ligands, ubiquitin-dependent proteasome degradation keeps the β-catenin protein at the basal level.(8) This process is controlled by a protein complex called the β-catenin destruction complex, which”
BackgroundVassallo, I., Zinn, P. O., Lai, M., Rajakannu, P., Hamou, M.-F., & Hegi, M. E. (2015) · Oncogene · doi:10.1038/onc.2015.61 · Cited by 140
Multi-omics enrichment analysis using the GeneTrail2 web service
Stöckel, D., Kehl, T., Trampert, P., Schneider, L., Backes, C., Ludwig, N., Gerasch, A., Kaufmann, M., Gessler, M., Graf, N. M., et al. (2016) · Bioinformatics · doi:10.1093/bioinformatics/btv770 · Cited by 145
“3.1.4 Activation of cancer-related WNT signaling Deregulation of the WNT signaling pathway is often prevalent in cancer samples (Polakis, 2012).”
BackgroundInfluentialRationale for targeting the Wnt signalling modulator Dickkopf‐1 for oncology
Kagey, M. H., & He, X. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13894 · Cited by 138
Cowan, A. D., & Ciulli, A. (2022) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-032620-104421 · Cited by 147
Maupin, K. A., Droscha, C. J., & Williams, B. O. (2013) · Bone Research · doi:10.4248/br201301004 · Cited by 142
Januar, V., Desoyé, G., Novakovic, B., Cvitic, S., & Saffery, R. (2015) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.07.011 · Cited by 140
Dietrich, L., Rathmer, B., Ewan, K., Bange, T., Heinrichs, S., Dale, T. C., Schade, D., & Grossmann, T. N. (2017) · Cell Chemical Biology · doi:10.1016/j.chembiol.2017.06.013 · Cited by 126
“In an oncogenic context, hyperactivation of Wnt signaling is often triggered by a reduction of destruction complex activity, e.g. via mutations in APC, Axin or β-catenin itself, resulting in high levels of β-catenin (Polakis 2012).”
Mechanical Control of Epithelial-to-Mesenchymal Transitions in Development and Cancer
Przybyla, L., Muncie, J. M., & Weaver, V. M. (2016) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-111315-125150 · Cited by 134
Islam, F., Gopalan, V., Smith, R. A., & Lam, A. K.-Y. (2015) · Experimental Cell Research · doi:10.1016/j.yexcr.2015.04.018 · Cited by 145
Wahab, N. A. A., Lajis, N. H., Abas, F., Othman, I., & Naidu, R. (2020) · Nutrients · doi:10.3390/nu12030679 · Cited by 133
Differences and similarities between cancer and somatic stem cells: therapeutic implications
Rossi, F., Noren, H., Jove, R., Beljanski, V., & Grinnemo, K. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-02018-6 · Cited by 130
Sulindac metabolites decrease cerebrovascular malformations in CCM3 -knockout mice
Bravi, L., Rudini, N., Cuttano, R., Giampietro, C., Maddaluno, L., Ferrarini, L., Adams, R. H., Corada, M., Boulday, G., Tournier‐Lasserve, E., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1501352112 · Cited by 125
“Similar sequential activation of different signaling pathways after early β-catenin signaling has been reported in epithelial transformation in colon cancer (30).”
Fu, Y., Huang, B., Shi, Z., Han, J., Wang, Y., Huangfu, J., & Wu, W. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201202218 · Cited by 118
“It is also crucial for tissue stem cells regulation, and its impairment is heavily linked to tumorigenesis (Clevers & Nusse, 2012; de Sousa et al, 2011; Polakis, 2012b; Schepers & Clevers, 2012).”
Nile, A. H., Mukund, S., Stanger, K., Wang, W., & Hannoush, R. N. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1618293114 · Cited by 118
Primary cilia: Cell and molecular mechanosensors directing whole tissue function
Spasić, M. R., & Jacobs, C. R. (2017) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2017.08.036 · Cited by 138
A comprehensive review of SHP2 and its role in cancer
Asmamaw, M. D., Shi, X.-J., Zhang, L.-R., & Liu, H.-M. (2022) · Cellular Oncology · doi:10.1007/s13402-022-00698-1 · Cited by 119
“In TNBC, dysregulated expression of cytoplasmic and nuclear β-catenin is observed even in the absence of Wnt signaling dysregulation [252, 253].”
BackgroundLIG4 mediates Wnt signalling-induced radioresistance
Jun, S., Jung, Y., Suh, H. N., Wang, W., Kim, M. J., Oh, Y. S., Lien, E. M., Shen, X. H., Matsumoto, Y., McCrea, P. D., et al. (2016) · Nature Communications · doi:10.1038/ncomms10994 · Cited by 119
Mammary Development and Breast Cancer: A Wnt Perspective
Yu, Q. C., Verheyen, E. M., & Zeng, Y. A. (2016) · Cancers · doi:10.3390/cancers8070065 · Cited by 122
“Although Wnt pathway mutations are rarely found in human breast cancer, hyperactive signaling is apparent, particularly in TNBC or basal-like types (reviewed in [157]).”
BackgroundEchinococcus–Host Interactions at Cellular and Molecular Levels
Brehm, K., & Koziol, U. (2016) · Advances in Parasitology/Advances in parasitology · doi:10.1016/bs.apar.2016.09.001 · Cited by 121
Tetrandrine and cancer – An overview on the molecular approach
Bhagya, N., & Chandrashekar, K. R. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.10.116 · Cited by 114
Wu, K., Ning, Z., Zeng, J., Fan, J., Zhou, J., Zhang, T., Zhang, L., Chen, Y., Gao, Y., Wang, B., et al. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.08.028 · Cited by 115
Chartier, C., Raval, J., Axelrod, F. T., Bond, C., Cain, J., Dee-Hoskins, C., Ma, S., Fischer, M. M., Shah, J., Wei, J., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-0561 · Cited by 111
“Cancer Res; 76(3) February 1, 2016 Cancer Research 720”
BackgroundInfluentialPoly(ADP-ribose) polymerase enzymes and the maintenance of genome integrity
Eisemann, T., & Pascal, J. M. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03366-0 · Cited by 118
Oncolytic Viruses: Exploiting Cancer's Deal with the Devil
Pikor, L. A., Bell, J. C., & Diallo, J. (2015) · Trends in cancer · doi:10.1016/j.trecan.2015.10.004 · Cited by 118
“Sustained activation of Wnt is associated with tumor initiation, uncontrolled growth, differentiation, and metastasis [33,34].”
BackgroundDissecting miRNA signature in colorectal cancer progression and metastasis
Huang, X., Zhu, X., Yu, Y., Zhu, W., Jin, L., Zhang, X., Li, S., Zou, P., Xie, C., & Cui, R. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.12.025 · Cited by 112
Molecular functions of NEDD4 E3 ubiquitin ligases in cancer
Zou, X., Levy‐Cohen, G., & Blank, M. (2015) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2015.06.005 · Cited by 108
Pathogenetic mechanisms in gastric cancer
Shi, J., Qu, Y.-P., & Hou, P. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i38.13804 · Cited by 113
Drug delivery system targeting advanced hepatocellular carcinoma: Current and future
Zhang, X., Ng, H. L. H., Lü, A., Lin, C., Zhou, L., Lin, G., Zhang, Y., Yang, Z., & Zhang, H. (2016) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2015.12.381 · Cited by 111
Metadata
- Authors
- Polakis, P.
- Affiliations
- Genentech (US)
- Corresponding author
- Polakis, P.
- Venue
- Cold Spring Harbor Perspectives in Biology
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2012-03-20
- Volume
- 4
- Issue
- 5
- Pages
- a008052-a008052
- ISSN
- 1943-0264 (ISSN-L)
- PMC
- PMC3331705
- OpenAlex
- W2149598894
- Cited by
- 847
- References
- 94
- Citations by year
- 2026: 13 · 2025: 21 · 2024: 41 · 2023: 36 · 2022: 56 · 2021: 85 · 2020: 76 · 2019: 77 · 2018: 76 · 2017: 95 · 2016: 89 · 2015: 64 · 2014: 54 · 2013: 51 · 2012: 13
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cold Spring Harbor Perspectives in Biology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Hedgehog Signaling Pathway Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- Wnt signaling, cancer, epigenetic regulation, Wnt inhibitors, malignant transformation, tumor genome sequencing
- MeSH terms
- Humans, Models, Biological, Mutation, Neoplasms, Oncogene Proteins, Tumor Suppressor Proteins, Epigenesis, Genetic, Wnt Signaling Pathway
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.